Bone Density Reduction: Tenofovir continues to be connected to a decrease in bone mineral density, raising the chance of bone difficulties or fractures.HIV-1 infected subjects on dolutegravir monotherapy demonstrated quick and dose-dependent reduction of antiviral exercise with declines of HIV-1 RNA copies for every ml. The antiviral response was m